Pyrrole substituted 2-indolinone protein kinase inhibitors
US7125905B2 · kind B2 · utility
38Cited by
84References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2005 |
| Grant date | Oct 24, 2006 |
| Priority date | — |
| Expiry date | Jan 4, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.